Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein

Science

Volumn 273, Issue 5277, 1996, Pages 951-953

  Desbois, Christelle ^a   Rousset, Raphaël ^a   Bantignies, Frédéric ^a   Jalinot, Pierre ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TAX PROTEIN;

ARTICLE; CARCINOGENICITY; CELL NUCLEUS INCLUSION BODY; CELL PROLIFERATION; CELLULAR DISTRIBUTION; GENE EXPRESSION; HUMAN T CELL LEUKEMIA VIRUS 1; MOLECULAR CLONING; ONCOGENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0029789753     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.273.5277.951     Document Type: Article

References (40)

1. B. J. Poiesz et al., Proc. Natl. Acad. Sci. U.S.A. 77. 7415 (1980); M. Yoshida, I. Miyoshi, Y. Hinuma, ibid. 79, 2031 (1982); A. Gessain et al., Lancet ii, 407 (1985); M. Osame et al., ibid. i, 1031 (1986).
2. B. J. Poiesz et al., Proc. Natl. Acad. Sci. U.S.A. 77. 7415 (1980); M. Yoshida, I. Miyoshi, Y. Hinuma, ibid. 79, 2031 (1982); A. Gessain et al., Lancet ii, 407 (1985); M. Osame et al., ibid. i, 1031 (1986).
3. B. J. Poiesz et al., Proc. Natl. Acad. Sci. U.S.A. 77. 7415 (1980); M. Yoshida, I. Miyoshi, Y. Hinuma, ibid. 79, 2031 (1982); A. Gessain et al., Lancet ii, 407 (1985); M. Osame et al., ibid. i, 1031 (1986).
4. B. J. Poiesz et al., Proc. Natl. Acad. Sci. U.S.A. 77. 7415 (1980); M. Yoshida, I. Miyoshi, Y. Hinuma, ibid. 79, 2031 (1982); A. Gessain et al., Lancet ii, 407 (1985); M. Osame et al., ibid. i, 1031 (1986).
5. M. Nerenberg, S. H. Hinrichs, R. K. Reynolds, G. Khoury, G. Jay, Science 237, 1324 (1987); R. Grassmann et al., Proc. Natl. Acad. Sci. U.S.A. 86, 3351 (1989); A. Tanaka et al. , ibid. 87, 1071 (1990); R, Pozzatti, J. Vogel, G. Jay, Mol. Cell. Biol. 10, 413 (1990).
6. M. Nerenberg, S. H. Hinrichs, R. K. Reynolds, G. Khoury, G. Jay, Science 237, 1324 (1987); R. Grassmann et al., Proc. Natl. Acad. Sci. U.S.A. 86, 3351 (1989); A. Tanaka et al. , ibid. 87, 1071 (1990); R, Pozzatti, J. Vogel, G. Jay, Mol. Cell. Biol. 10, 413 (1990).
7. M. Nerenberg, S. H. Hinrichs, R. K. Reynolds, G. Khoury, G. Jay, Science 237, 1324 (1987); R. Grassmann et al., Proc. Natl. Acad. Sci. U.S.A. 86, 3351 (1989); A. Tanaka et al. , ibid. 87, 1071 (1990); R, Pozzatti, J. Vogel, G. Jay, Mol. Cell. Biol. 10, 413 (1990).
8. M. Nerenberg, S. H. Hinrichs, R. K. Reynolds, G. Khoury, G. Jay, Science 237, 1324 (1987); R. Grassmann et al., Proc. Natl. Acad. Sci. U.S.A. 86, 3351 (1989); A. Tanaka et al. , ibid. 87, 1071 (1990); R, Pozzatti, J. Vogel, G. Jay, Mol. Cell. Biol. 10, 413 (1990).
9. P. Sarnow, Y. S. Ho, J. Williams, A. J. Levine, Cell 28, 387 (1982); B. A. Werness, A. J. Levine, P. M. Howley, Science 248, 76 (1990); J. A. DeCaprio et al. , Cell 54, 275 (1988); P. Whyte et al., Nature 334, 124 (1988); N. Dyson, P. M. Howley, K. Münger, E. Harlow, Science 243, 934 (1989).
10. P. Sarnow, Y. S. Ho, J. Williams, A. J. Levine, Cell 28, 387 (1982); B. A. Werness, A. J. Levine, P. M. Howley, Science 248, 76 (1990); J. A. DeCaprio et al. , Cell 54, 275 (1988); P. Whyte et al., Nature 334, 124 (1988); N. Dyson, P. M. Howley, K. Münger, E. Harlow, Science 243, 934 (1989).
11. P. Sarnow, Y. S. Ho, J. Williams, A. J. Levine, Cell 28, 387 (1982); B. A. Werness, A. J. Levine, P. M. Howley, Science 248, 76 (1990); J. A. DeCaprio et al. , Cell 54, 275 (1988); P. Whyte et al., Nature 334, 124 (1988); N. Dyson, P. M. Howley, K. Münger, E. Harlow, Science 243, 934 (1989).
12. P. Sarnow, Y. S. Ho, J. Williams, A. J. Levine, Cell 28, 387 (1982); B. A. Werness, A. J. Levine, P. M. Howley, Science 248, 76 (1990); J. A. DeCaprio et al. , Cell 54, 275 (1988); P. Whyte et al., Nature 334, 124 (1988); N. Dyson, P. M. Howley, K. Münger, E. Harlow, Science 243, 934 (1989).
13. P. Sarnow, Y. S. Ho, J. Williams, A. J. Levine, Cell 28, 387 (1982); B. A. Werness, A. J. Levine, P. M. Howley, Science 248, 76 (1990); J. A. DeCaprio et al. , Cell 54, 275 (1988); P. Whyte et al., Nature 334, 124 (1988); N. Dyson, P. M. Howley, K. Münger, E. Harlow, Science 243, 934 (1989).
14. S. Fields and O.-K. Song, Nature 340, 245 (1989).
15. T. Durfee et al., Genes Dev. 7, 555 (1993).
16. We used the MATCHMAKER two-hybrid system (Clontech, Palo Alto, CA). The Tax coding sequence was fused to the GAL4 DNA binding domain into the pGB-T9 yeast expression vector, giving pGB-Tax. The human cDNA library we used has been described (5). Briefly, cDNAs from EBV-transformed human peripheral lymphocytes were fused to the GAL4 transcriptional activation domain into the λACT phage vector. pGB-Tax was introduced into the HF7c yeast strain, and the resulting cells were transformed by the fusion cDNA library. The HF7c strain possesses the His synthetase gene (HIS3) and the lacZ gene under the control of GAL4 binding sites. From an initial screen of 250,000 transformants, 700 were found to grow on a minimal medium lacking His. Of these, 94 were also positive when assayed for β-galactosidase expression. Plasmid DNAs from the double positive clones were extracted and sequenced.
17. A. Marchetti et al., J. Virol. 69, 1932 (1995).
18. C. Caron et al., EMBO J. 12, 4269 (1993).
19. Forty hours after transfection by the calcium phosphate precipitation method, cells were fixed for 15 min in 4% paraformaldehyde, followed by 20 min in 0.1 M glycine, and permeabilized for 5 min in 0.5% Triton X-100. Cells were then incubated for 1 hour with the monoclonal antibody M2 (Kodak) directed against the FLAG epitope or Tax antiserum. After washing, cells were further incubated for 45 min with appropriate secondary antibodies conjugated with fluorescein or rhodamine. Finally, nuclei were stained with Hoechst 33258.
20. M. Sugawara, T. Scholl, P. D. Ponath, J. L. Strominger, Mol. Cell. Biol. 14, 8438 (1994).
21. C. Desbois, R. Rousset, F. Bantignies, P. Jalinot, data not shown.
22. C. A. Ascoli and G. G. Maul, J. Cell Biol. 112, 785 (1991).
23. P. Kastner et al., EMBO J. 11, 629 (1992).
24. J. A. Dyck et al., Cell 76, 333 (1994).
25. K. Weis et al., ibid., p. 345.
26. Immunofluorescence experiments were performed as described for Fig. 3. Cells were examined with a confocal laser scan microscope (Zeiss). Fluorescein was excited at 488 nm, and rhodamine, at 543 nm. The two channels were recorded independently. Pseudocolor images were generated and superimposed with Photoshop software.
27. A. Kakizuka et al., Cell 66, 663 (1991); H. de Thé et al., ibid., p. 675; A. D. Goddard. J. Borrow, P. S. Freemont, E. Solomon, Science 254, 1371 (1991); P. P. Pandolfi et al., Oncogene 6, 1285 (1991).
28. A. Kakizuka et al., Cell 66, 663 (1991); H. de Thé et al., ibid., p. 675; A. D. Goddard. J. Borrow, P. S. Freemont, E. Solomon, Science 254, 1371 (1991); P. P. Pandolfi et al., Oncogene 6, 1285 (1991).
29. A. Kakizuka et al., Cell 66, 663 (1991); H. de Thé et al., ibid., p. 675; A. D. Goddard. J. Borrow, P. S. Freemont, E. Solomon, Science 254, 1371 (1991); P. P. Pandolfi et al., Oncogene 6, 1285 (1991).
30. A. Kakizuka et al., Cell 66, 663 (1991); H. de Thé et al., ibid., p. 675; A. D. Goddard. J. Borrow, P. S. Freemont, E. Solomon, Science 254, 1371 (1991); P. P. Pandolfi et al., Oncogene 6, 1285 (1991).
31. M. H. Koken et al., EMBO J. 13, 1073 (1994).
32. B. Terris et al., Cancer Res. 55, 1590 (1995).
33. U. M. Moll, G. Riou, A. J. Levine, Proc. Natl. Acad. Sci. U.S.A 89, 7262 (1992).
34. 6) were transfected by the calcium phosphate precipitation method with 1 μg of the pG4G3CAT reporter construct (8), 10 ng of pG4M or pSG4-Tax (8), and 100 ng of pSG-FNV or pSG-FNV-70. pSG-FNV is a pSG5 derivative encoding the FLAG epitope fused to the SV40 nuclear localization signal and to the VP16 activation domain (amino acids 403 to 479). The clone 70 Int-6 cDNA was inserted into this parental plasmid to give pSG-FNV-70. Duplicate transfections were done for each combination of plasmids Forty hours after transfection, concentrations of the CAT protein were measured by enzyme-linked immunosorbent assay (Boehringer Mannheim).
35. S. M. Hanly et al., Genes Dev. 3, 1534 (1989).
36. 6) were transfected with 1 μg of pSGF-Int-6 or 1 μg of pSG-Tax, or both. Cells were lysed in radioimmunoprecipitation assay buffer. The immunoprecipitates were separated on a 10% polyacrylamide-SDS gel and blotted onto nitrocellulose. The enhanced chemiluminescent detection system (ECL, Amersham) was used to visualize bound antibodies.
37. We generated a polyclonal rabbit antiserum to a peptide corresponding to the COOH-terminal 20 amino acids of Int-6 coupled to ovalbumin. To purify this serum, we produced a FLAG-Int-6 fusion protein in bacteria and coupled it to a FLAG M2 antibody affinity gel (Kodak). Covalent linkage between the protein and the M2 antibody was performed by treatment with glutaraldehyde. The antiserum to Int-6 was incubated with this matrix, and specific antibodies were eluted with 100 mM glycine (pH 2.5).
38. N. Stuurman et al., J. Cell Sci. 101, 773 (1992); G.G. Maul, E. Yu, A. M. Ishov, A. L. Epstein, J. Cell. BioChem. 59, 498 (1995).
39. N. Stuurman et al., J. Cell Sci. 101, 773 (1992); G.G. Maul, E. Yu, A. M. Ishov, A. L. Epstein, J. Cell. BioChem. 59, 498 (1995).
40. We thank S. Elledge for providing the cDNA library; B. Cullen for the antiserum to Tax; A. Dejean for the PML rabbit polyclonal serum; R. van Driel for the PML monoclonal antibody; P. Chambon for the PML expression vector; C. Souchier for help with confocal microscopy; F. Chatelet for assistance in preparing the figures; and J. Maryanski for critical reading of the manuscript. This work was supported by the Agence Nationale de Recherches sur le Sida and the Association pour la Recherche contre le Cancer (F.B.).